Melissa K Accordino

21PUBLICATIONS
212CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsMultimorbidityCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Oct 07, 2025
Where Have We Been and Where Are We Going? The State of the Hematology and Medical Oncologist Workforce in America.

M Kelsey Kirkwood, Erin P Balogh, Melissa K Accordino

|Oct 06, 2025
ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States.

Erin P Balogh, Laura A Levit, Joseph M Unger

|Sep 30, 2024
Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs.

Morgan R L Lichtenstein, Peter Campbell, Rohit Raghunathan

Pageof 4